IP Library Granted Patent US 9,265,759
Granted Patent B2
US 9,265,759 · App. 14/581,462 · Granted Feb 23, 2016

Compositions and methods of treating retinal disease

Inventors: Thomas A. Jordan (Lexington, MA); John E. Dowling (Boston, MA); John Clifford Chabala (Scotch Plains, NJ)
Assignee: Aldeyra Therapeutics, Inc.
A61K31/47A61K31/41A61K31/423A61K31/426A61K31/435A61K31/4706C07C215/68C07C229/56C07C229/60C07D215/38C07D277/40C07D277/56
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,265,759
App. No.
14/581,462
Granted
Feb 23, 2016
Kind
B2
Abstract

Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed.

Claims (15)

1. A method of treating macular degeneration and other forms of retinal disease mediated by the accumulation of A2E and/or lipofuscin in a subject, the method comprising administering to the subject a composition comprising a compound of formula Ia:

or a pharmaceutically acceptable salt of Ia,

wherein

X is CH;

Z is N;

Y is C with the —NH 2 attached to Y;

p is 1, 2, or 3;

B is a halogen atom, hydroxyl, carbamoyl, substituted or unsubstituted aryl or amino wherein substituted aryl has one or more substituents selected from halogen, hydroxyl, alkoxy, alkylcarbonyloxy, arylcarbonyloxy, alkoxycarbonyloxy, aryloxycarbonyloxy, carboxylate, alkylcarbonyl, alkylaminocarbonyl, aralkylaminocarbonyl, alkenylaminocarbonyl, arylcarbonyl, aralkylcarbonyl, alkenylcarbonyl, alkoxycarbonyl, aminocarbonyl, alkylthiocarbonyl, phosphate, phosphonato, phosphinato, cyano, amino, alkylamino, dialkylamino, arylamino, diarylamino, alkylarylamino, acylamino, alkylcarbonylamino, arylcarbonylamino, carbamoyl, ureido, amidino, imino, sulfhydryl, alkylthio, arylthio, thiocarboxylate, sulfates, alkylsulfinyl, sulfamoyl, sulfonamido, nitro, trifluoromethyl, azido, heterocyclyl, alkylaryl, an aromatic moiety and a heteroaromatic moiety;

A is

D is unbranched lower alkyl; and

R is substituted or unsubstituted C1, C2, C3, C4, C5, C6, C7, or C8 straight chain alkyl, or substituted or unsubstituted C3, C4, C5, C6, C7or C8 branched chain alkyl wherein said substituted straight chain alkyl or said substituted branched chain alkyl has one or more substituents selected from alkyl, alkenyl, alkynyl, halogen, hydroxyl, alkylcarbonyloxy, arylcarbonyloxy, alkoxycarbonyloxy, aryloxycarbonyloxy, carboxylate, alkylcarbonyl, arylcarbonyl, alkoxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkylthiocarbonyl, alkoxyl, phosphate, phosphonato, phosphinato, cyano, amino, alkylamino, dialkylamino, arylamino, diarylamino, alkylarylamino, acylamino, alkylcarbonylamino, arylcarbonylamino, carbamoyl, ureido, amidino, imino, sulfhydryl, alkylthio, arylthio, thiocarboxylate, sulfates, alkylsulfinyl, sulfamoyl, sulfonamido, trifluoromethyl, azido, heterocyclyl, alkylaryl, an aromatic moiety and a heteroaromatic moiety.

2. The method of claim 1 , wherein p is 1.

3. The method of claim 2 , wherein A is

4. The method of claim 3 , wherein D is CH 3 .

5. The method of claim 4 , wherein B is a halogen atom.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Dec 5, 2018
From: PACIFIC WESTERN BANK (SUCCESSOR BY MERGER TO SQUARE 1 BANK)
To: ALDEYRA THERAPEUTICS, INC. (F/K/A ALDEXA THERAPEUTICS, INC. F/K/A NEURON SYSTEMS, INC.)
Reel/Frame 047683/0482 →
SECURITY INTEREST Recorded Dec 7, 2016
From: ALDEYRA THERAPEUTICS, INC. (F/K/A ALDEXA THERAPEUTICS, INC.)
To: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
Reel/Frame 040589/0196 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2015
From: JORDAN, THOMAS A.; DOWLING, JOHN E.; CHABALA, JOHN CLIFFORD
To: NEURON SYSTEMS, INC.
Reel/Frame 037365/0630 →
CHANGE OF ADDRESS Recorded Dec 28, 2015
From: NEURON SYSTEMS, INC.
To: NEURON SYSTEMS, INC.
Reel/Frame 037393/0995 →
CHANGE OF NAME Recorded Dec 28, 2015
From: NEURON SYSTEMS, INC.
To: ALDEXA THERAPEUTICS, INC.
Reel/Frame 037394/0030 →
CHANGE OF NAME Recorded Aug 28, 2015
From: ALDEXA THERAPEUTICS, INC.
To: ALDEYRA THERAPEUTICS, INC.
Reel/Frame 036504/0756 →
Continuity (5)
Continuation 13175218 · Jul 1, 2011
Continuation 11441848 · May 26, 2006
Provisional Application 60723577 · Oct 4, 2005
Provisional Application 60685460 · May 26, 2005
Related Publication 20150209345A1 · Jul 30, 2015